BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Fusion and connection of classical and new chemical modalities for
  ‘undruggable’ targets
DTSTART:20180226T170000
DTEND:20180226T180000
DTSTAMP:20260917T070533Z
UID:791e4a8e9b5107e498146de0857f02ef91aa3d6f8b954cbee84dcda5
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr. Eric Valeur\, AstraZeneca\nEric Valeur is Associate Direc
 tor for New Modalities at AstraZeneca. He is driving research within the c
 hemical space at the interface of small and large molecules. His present r
 esearch interests include small molecules\, peptides\, macrocycles\, oligo
 nucleotides and conjugates thereof.
LOCATION:BCH 5310 https://plan.epfl.ch/?room==BCH%205310
STATUS:CANCELLED
END:VEVENT
END:VCALENDAR